Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy

Clinical trial NCT06687876 · RECRUITING

Trial details

NCT number: NCT06687876
Sponsor: Amsterdam UMC, location VUmc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oesophageal Adenocarcinoma Tumor Microenvironment

Start date: 2025-03-09
Primary completion: 2026-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.